Xi-xi Li
1Department Of Hematology, 8 Dianli Rd
Zhenjiang, 212002, China
Zhenjiang, 212002, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Clinical Study of SCIN Expression and Dromoter Methylation in Patients with Chronic Myeloid Leukemia
Clinical Study of SCIN Expression and Dromoter Methylation in Patients with Chronic Myeloid Leukemia
Journal: Zhongguo shi yan xue ye xue za zhi
Published: June 18, 2019
BCL2 overexpression: clinical implication and biological insights in acute myeloid leukemia.
Journal: Diagnostic pathology
Published: March 18, 2019
MicroRNA-335/ID4 dysregulation predicts clinical outcome and facilitates leukemogenesis by activating PI3K/Akt signaling pathway in acute myeloid leukemia.
Journal: Aging
Published: March 12, 2019
Increased MCL-1 expression predicts poor prognosis and disease recurrence in acute myeloid leukemia.
Increased MCL-1 expression predicts poor prognosis and disease recurrence in acute myeloid leukemia.
Journal: OncoTargets and therapy
Published: November 14, 2018
Hypermethylation of ITGBL1 is associated with poor prognosis in acute myeloid leukemia.
Journal: Journal of cellular physiology
Published: June 28, 2018
Lower expression of bone marrow miR-122 is an independent risk factor for overall survival in cytogenetically normal acute myeloid leukemia.
Journal: Pathology, research and practice
Published: February 14, 2018
Identification and validation of SRY-box containing gene family member SOX30 methylation as a prognostic and predictive biomarker in myeloid malignancies.
Journal: Clinical epigenetics
Published: February 12, 2018
Overexpression of CTNNB1: Clinical implication in Chinese de novo acute myeloid leukemia.
Journal: Pathology, research and practice
Published: November 16, 2017
Bone marrow miR-10a overexpression is associated with genetic events but not affects clinical outcome in acute myeloid leukemia.
Journal: Pathology, research and practice
Published: October 03, 2017
H19 overexpression promotes leukemogenesis and predicts unfavorable prognosis in acute myeloid leukemia.
Journal: Clinical epigenetics
Published: September 22, 2017
Methylation-associated DOK1 and DOK2 down-regulation: Potential biomarkers for predicting adverse prognosis in acute myeloid leukemia.
Journal: Journal of cellular physiology
Published: August 22, 2017
Methylation-independent CHFR expression is a potential biomarker affecting prognosis in acute myeloid leukemia.
Journal: Journal of cellular physiology
Published: August 06, 2017
Last Updated: 09/26/2026